After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ONLY a year after they stepped onto the dance floor at Glaxo Sports and Social Club in Barney, a Startforth couple are now ...

23andMe is a company on the ropes. The one-time leader of the DNA analysis market – valued at $6 billion in 2021 – is now ...

GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...

The history of the pharmaceutical industry in the town goes back to the post-war era, when Glaxo built a production site on a former iron works. At the time, pharmaceutical production sites were ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

On Monday, the market opened weak with a gap-down start, and despite a brief recovery attempt, selling pressure remained dominant throughout the session. Nifty faced relentless resistance, with ...

GlaxoSmithKline Pharmaceuticals shares hit 20 per cent upper circuit in trade on BSE at Rs 2,421.3 per share. The buying on the counter came after the company posted its Q3 results. Around 9:52 AM, ...